YSS Deadline: YSS Investors Have Opportunity to Lead York Space Systems Inc. Securities Lawsuit

  • Post author:
  • Post category:Business

NEW YORK, Oct. 25, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of York Space Systems Inc. (NYSE: YSS): (i) common stock pursuant and/or traceable to the registration statement and prospectus (collectively,…

Continue ReadingYSS Deadline: YSS Investors Have Opportunity to Lead York Space Systems Inc. Securities Lawsuit

Clarins Lights Up the Austin Skyline with an Immersive Celebration of Skin Longevity

AUSTIN, Texas, Oct. 25, 2026 /PRNewswire/ -- French prestige beauty brand, Clarins, hosted an exclusive rooftop celebration in Austin, Texas, bringing together science, technology and innovation to celebrate its iconic Double Serum and a new era of Double…

Continue ReadingClarins Lights Up the Austin Skyline with an Immersive Celebration of Skin Longevity

Lubbock Plastic Surgeon Dr. Thanapoom Boonipat Leads Suturing Workshop for Texas Tech Women in STEM Premed Students

Suturing workshopLUBBOCK, Texas, Oct. 25, 2026 /PRNewswire/ -- Dr. Thanapoom "Mo" Boonipat, plastic surgeon and founder of FacePlus Plastic Surgery Institute in Lubbock, led a hands-on suturing workshop and career Q&A session for premed students at Texas Tech…

Continue ReadingLubbock Plastic Surgeon Dr. Thanapoom Boonipat Leads Suturing Workshop for Texas Tech Women in STEM Premed Students

Miranda Lambert To Kick Off Salvation Army’s Red Kettle Campaign With Dallas Cowboys Thanksgiving Game Halftime Performance

This year marks the 30th anniversary of iconic artists inspiring giving with live, nationally televised performances during the most-watched regular season gameFRISCO, Texas, Oct. 25, 2026 /PRNewswire/ -- Multi-Platinum, three-time Grammy Award-winning country music superstar Miranda Lambert will…

Continue ReadingMiranda Lambert To Kick Off Salvation Army’s Red Kettle Campaign With Dallas Cowboys Thanksgiving Game Halftime Performance

Vantrue Announces Early Black Friday Sale with Up to 44% Off Select Dash Cams

November 1–21, 2026 | Official Website: Vantrue.comSHENZHEN, China, Oct. 25, 2026 /PRNewswire/ -- Vantrue, a dash cam brand dedicated to helping drivers capture the road with confidence, is launching its three-week Black Friday campaign from November 1 to…

Continue ReadingVantrue Announces Early Black Friday Sale with Up to 44% Off Select Dash Cams

RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced head and neck cancer

  • Post author:
  • Post category:Sales & Growth

Responses were deep and durable, with 65% ongoing at clinical cutoffResults support continued evaluation of the investigational RYBREVANT FASPRO regimen in the ongoing first-line Phase 3 studyData highlight the role of dual-targeting EGFR and MET, key drivers of tumor growth…

Continue ReadingRYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced head and neck cancer

LexisNexis Coplogic Solutions Introduces Field Clarity for LexisNexis® Desk Officer Reporting System (DORS) at IACP 2026

A new, modern DORS and Field Clarity, the First AI-Guided Smartphone Video Assistant, Enhances Community Experience and Helps Improve Evidence, Case BuildingORLANDO, Fla., Oct. 25, 2026 /PRNewswire/ -- LexisNexis® Coplogic™ Solutions today announced its modernized LexisNexis® Desk Officer…

Continue ReadingLexisNexis Coplogic Solutions Introduces Field Clarity for LexisNexis® Desk Officer Reporting System (DORS) at IACP 2026

Final OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ESMO

  • Post author:
  • Post category:Business

Median OS was extended by 8.5 months compared with platinum-based doublet chemotherapy (25.9 vs 17.4 months), with a 31% reduction in the risk of death (HR 0.69; 95% CI 0.54–0.89; one-sided P = 0.0021).The 2-year OS rate was…

Continue ReadingFinal OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ESMO

Johnson & Johnson reports 75% tumor response rate in advanced prostate cancer with JNJ-6143, a first-in-class RIPTAC™ molecule

  • Post author:
  • Post category:Sales & Growth

JNJ-6143 is an investigational, once-daily, novel, small molecule designed to trigger cancer cell death through a targeted dual-protein lock between BRD4 and androgen receptor, a highly expressed tumor-selective protein in prostate cancer cellsAmong patients with measurable disease in…

Continue ReadingJohnson & Johnson reports 75% tumor response rate in advanced prostate cancer with JNJ-6143, a first-in-class RIPTAC™ molecule

Ping An Highlights Green Development Initiatives at International Communication Seminar in Shenzhen Ahead of APEC 2026

  • Post author:
  • Post category:Business

HONG KONG and SHANGHAI, Oct. 25, 2026 /PRNewswire/ -- The Seminar on International Communication of Chinese and Foreign Enterprises' Green Development and Global Contributions was held at the Ping An Finance Center in Shenzhen on October 23. Hosted by…

Continue ReadingPing An Highlights Green Development Initiatives at International Communication Seminar in Shenzhen Ahead of APEC 2026